benzo(a)pyrene has been researched along with Diabetes Mellitus, Type 1 in 1 studies
Benzo(a)pyrene: A potent mutagen and carcinogen. It is a public health concern because of its possible effects on industrial workers, as an environmental pollutant, an as a component of tobacco smoke.
benzo[a]pyrene : An ortho- and peri-fused polycyclic arene consisting of five fused benzene rings.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rizzo, M | 1 |
| Rizvi, AA | 1 |
| Sesti, G | 1 |
1 other study available for benzo(a)pyrene and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Cardiovascular effects of glucagon-like peptide-1 receptor agonist therapies in patients with type 1 diabetes.
Topics: Benzo(a)pyrene; Bronchi; Diabetes Mellitus, Type 1; DNA; Glucagon-Like Peptide-1 Receptor; Humans; H | 2017 |